Titan Pharmaceuticals - 48 Year Dividend History | TTNP

Historical dividend payout and yield for Titan Pharmaceuticals (TTNP) since 1971. The current TTM dividend payout for Titan Pharmaceuticals (TTNP) as of May 17, 2019 is $0.00. The current dividend yield for Titan Pharmaceuticals as of May 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.007B
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $103.634B 11.72
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.478B 51.02